| Date Filed | Type | Description |
| 11/26/2021 |
4
| Greenspan Ira Scott (Executive Committee Chairman) has filed a Form 4 on Scopus BioPharma Inc.|
Txns:
| Disposed of 3,000,000 options to buy
@ $4, valued at
$12M
|
|
| 11/26/2021 |
4
| Lamstein Joshua R (Chairman) has filed a Form 4 on Scopus BioPharma Inc.|
Txns:
| Disposed of 3,000,000 options to buy
@ $4, valued at
$12M
|
|
| 11/17/2021 |
4
| Hopper Paul (Director) has filed a Form 4 on Scopus BioPharma Inc.|
Txns:
| Acquired 700,000 shares
@ $0
Acquired 6,333 shares
@ $0 |
|
| 11/17/2021 |
3
| Hopper Paul (Director) has filed a Form 3 on Scopus BioPharma Inc. |
| 08/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2021 |
4
| Greenspan Ira Scott (Executive Committee Chairman) has filed a Form 4 on Scopus BioPharma Inc.|
Txns:
| Acquired 1,068,016 options to buy
@ $4, valued at
$4.3M
|
|
| 08/03/2021 |
4
| Lamstein Joshua R (Chairman) has filed a Form 4 on Scopus BioPharma Inc.|
Txns:
| Acquired convertible notes
@ $0.5, valued at
$0
Converted convertible notes
@ $0.5, valued at
$0
Acquired 16,963 options to buy
@ $4, valued at
$67.9k
Acquired 1,068,016 options to buy
@ $4, valued at
$4.3M
|
|
| 07/27/2021 |
4
| Greenspan Ira Scott (Executive Committee Chairman) has filed a Form 4 on Scopus BioPharma Inc.|
Txns:
| Bought 1,100 shares
@ $4.77, valued at
$5.2k
Bought 1,000 shares
@ $4.78, valued at
$4.8k
Bought 400 shares
@ $4.76, valued at
$1.9k
Bought 200 shares
@ $4.54, valued at
$908 |
|
| 07/27/2021 |
4
| Lamstein Joshua R (Chairman) has filed a Form 4 on Scopus BioPharma Inc.|
Txns:
| Bought 1,500 shares
@ $4.71, valued at
$7.1k
|
|
| 07/12/2021 |
3
| Horsager Alan M (See Remarks) has filed a Form 3 on Scopus BioPharma Inc. |
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2020 |
3
| Hofstein Raphael (Director) has filed a Form 3 on Scopus BioPharma Inc. |
| 12/28/2020 |
3
| Russell Lesley (Director) has filed a Form 3 on Scopus BioPharma Inc. |
| 12/28/2020 |
3
| Weild IV David (Director) has filed a Form 3 on Scopus BioPharma Inc. |
| 12/28/2020 |
3
| Battleman David S. (Director) has filed a Form 3 on Scopus BioPharma Inc. |
| 12/28/2020 |
3
| Buckel David A. (Director) has filed a Form 3 on Scopus BioPharma Inc. |
| 12/15/2020 |
3
| Gibson Robert J (Vice Chairman) has filed a Form 3 on Scopus BioPharma Inc. |
| 12/15/2020 |
3
| Sanghrajka Ashish P (President) has filed a Form 3 on Scopus BioPharma Inc. |
| 12/15/2020 |
3
| Greenspan Ira Scott (Director) has filed a Form 3 on Scopus BioPharma Inc. |
| 12/15/2020 |
3
| Lamstein Joshua R (Chairman) has filed a Form 3 on Scopus BioPharma Inc. |